Monitoring of mass distribution interventions for trachoma in Plateau State, Nigeria
- PMID: 23326617
- PMCID: PMC3542118
- DOI: 10.1371/journal.pntd.0001995
Monitoring of mass distribution interventions for trachoma in Plateau State, Nigeria
Abstract
Mass drug administration (MDA) with antibiotics is a key component of the SAFE strategy for trachoma control. Guidelines recommend that where MDA is warranted the whole population be targeted with 80% considered the minimum acceptable coverage. In other countries, MDA is usually conducted by salaried Ministry of Health personnel (MOH). In Plateau State, Nigeria, the existing network of volunteer Community Directed Distributors (CDD) was used for the first trachoma MDA. We conducted a population-based cluster random survey (CRS) of MDA participation to determine the true coverage and compared this to coverage reported from CDD registers. We surveyed 1,791 people from 352 randomly selected households in 24 clusters in three districts in Plateau State in January 2011, following the implementation of MDA. Households were enumerated and all individuals present were asked about MDA participation. Household heads were questioned about household-level characteristics and predictors of participation. Individual responses were compared with the CDD registers. MDA coverage was estimated as 60.3% (95% CI 47.9-73.8%) by the survey compared with 75.8% from administrative program reports. CDD registration books for comparison with responses were available in 19 of the 24 clusters; there was a match for 658/682 (96%) of verifiable responses. CDD registers did not list 481 (41.3%) of the individuals surveyed. Gender and age were not associated with individual participation. Overall MDA coverage was lower than the minimum 80% target. The observed discrepancy between the administrative coverage estimate from program reports and the CRS was largely due to identification of communities missed by the MDA and not reported in the registers. CRS for evaluation of MDA provides a useful additional monitoring tool to CDD registers. These data support modification of distributor training and MDA delivery to increase coverage in subsequent rounds of MDA.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia.Trop Med Int Health. 2019 Apr;24(4):493-501. doi: 10.1111/tmi.13208. Epub 2019 Feb 10. Trop Med Int Health. 2019. PMID: 30674087 Free PMC article.
-
Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.PLoS Negl Trop Dis. 2018 Feb 16;12(2):e0006270. doi: 10.1371/journal.pntd.0006270. eCollection 2018 Feb. PLoS Negl Trop Dis. 2018. PMID: 29451881 Free PMC article.
-
The cost of antibiotic mass drug administration for trachoma control in a remote area of South Sudan.PLoS Negl Trop Dis. 2011 Oct;5(10):e1362. doi: 10.1371/journal.pntd.0001362. Epub 2011 Oct 11. PLoS Negl Trop Dis. 2011. PMID: 22022632 Free PMC article.
-
Methods for estimating population coverage of mass distribution programmes: a review of practices in relation to trachoma control.Trans R Soc Trop Med Hyg. 2012 Oct;106(10):588-95. doi: 10.1016/j.trstmh.2012.07.011. Epub 2012 Aug 9. Trans R Soc Trop Med Hyg. 2012. PMID: 22884927 Review.
-
Ocular Chlamydia trachomatis infection: elimination with mass drug administration.Expert Rev Anti Infect Ther. 2019 Mar;17(3):189-200. doi: 10.1080/14787210.2019.1577136. Epub 2019 Feb 18. Expert Rev Anti Infect Ther. 2019. PMID: 30698042 Free PMC article. Review.
Cited by
-
Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017.PLoS Negl Trop Dis. 2019 Dec 16;13(12):e0007924. doi: 10.1371/journal.pntd.0007924. eCollection 2019 Dec. PLoS Negl Trop Dis. 2019. PMID: 31841516 Free PMC article.
-
To eliminate trachoma: Azithromycin mass drug administration coverage and associated factors among adults in Goro district, Southeast Ethiopia.PLoS Negl Trop Dis. 2022 Jun 27;16(6):e0010169. doi: 10.1371/journal.pntd.0010169. eCollection 2022 Jun. PLoS Negl Trop Dis. 2022. PMID: 35759466 Free PMC article.
-
Comparison of Reported and Survey-Based Coverage in Onchocerciasis Programs over a Period of 8 Years in Cameroon and Uganda.Am J Trop Med Hyg. 2019 May;100(5):1208-1215. doi: 10.4269/ajtmh.18-0680. Am J Trop Med Hyg. 2019. PMID: 30915956 Free PMC article.
-
Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.Am J Trop Med Hyg. 2018 Aug;99(2):396-403. doi: 10.4269/ajtmh.17-1004. Epub 2018 Jun 21. Am J Trop Med Hyg. 2018. PMID: 29943709 Free PMC article.
-
Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin-Piperaquine in Southern Province, Zambia.Am J Trop Med Hyg. 2020 Aug;103(2_Suppl):19-27. doi: 10.4269/ajtmh.19-0665. Am J Trop Med Hyg. 2020. PMID: 32618251 Free PMC article. Clinical Trial.
References
-
- Mariotti SP, Pascolini D, Rose-Nussbaumer J (2009) Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 93: 563–568. - PubMed
-
- WHO (2012) Global WHO Alliance for the Elimination of Blinding Trachoma by 2020. Wkly Epidemiol Rec 87: 161–168. - PubMed
-
- WHO. (2006) Trachoma control: a guide for program managers. Geneva, World Health Organization.
-
- Jip NF, King JD, Diallo MO, Miri ES, Hamza AT, et al. (2008) Blinding trachoma in katsina state, Nigeria: population-based prevalence survey in ten local government areas. Ophthalmic Epidemiol 15: 294–302. - PubMed
-
- King JD, Jip N, Jugu YS, Othman A, Rodgers AF, et al. (2010) Mapping trachoma in Nasarawa and Plateau States, central Nigeria. Br J Ophthalmol 94: 14–19. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical